About: Spironolactone prevents diabetic nephropathy through an anti-inflammatory mechanism in type 2 diabetic rats

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Spironolactone prevents diabetic nephropathy through an anti-inflammatory mechanism in type 2 diabetic rats Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific journal article

Attributes	Values
rdf:type	Item
description	article scientifique publié en 2006 (fr) artículu científicu espublizáu en 2006 (ast) vědecký článek publikovaný v roce 2006 (cs) 2006 թուականի Մայիսին հրատարակուած գիտական յօդուած (hyw) наукова стаття, опублікована в травні 2006 (uk) 2006 թվականի մայիսին հրատարակված գիտական հոդված (hy) مقالة علمية (نشرت في مايو 2006) (ar) vedecký článok (publikovaný 2006/05/01) (sk) wetenschappelijk artikel (gepubliceerd op 2006/05/01) (nl) scientific journal article (en) im Mai 2006 veröffentlichter wissenschaftlicher Artikel (de)
publication date	wds:Q28565932-FD1C33EE-E537-4BE7-9578-4D80487A50E1
publication date	2006-05-01 00:00:00Z (xsd:dateTime)
author name string	wds:Q28565932-090C86E7-3F1A-4BF7-BF81-B1ADA15646BD wds:Q28565932-1333A908-57EF-4253-8CD2-2C9610BA16A5 wds:Q28565932-664DA14F-9A87-4E51-8DE8-134B080B24C2 wds:Q28565932-78D53720-F2CB-4E6D-9365-C0F788BAD16A wds:Q28565932-7A182E4B-6C39-437F-930D-453701624EED wds:Q28565932-85EB0EDA-6627-4A18-8B05-7D94EE709CEF wds:Q28565932-8E56A73F-FB59-4DDF-873A-BB98E77C32BD wds:Q28565932-95E3C06B-B3E2-480D-A644-777C59639012 wds:Q28565932-B1D1701F-608D-456E-99BE-BD8E4283F356 wds:Q28565932-C175CEF9-2013-490D-83C7-3E1AAA9E2A4C wds:Q28565932-C3A6345B-31B0-4F95-8E55-1A3C8D0AC182 wds:Q28565932-E2A775B8-EA2E-41DA-8C96-900B34F928E2
OpenCitations bibliographic resource ID	wds:Q28565932-115DBB03-54D6-4B4F-B5A1-9477E77C728E
OpenCitations bibliographic resource ID	https://w3id.org/oc/corpus/br/4087431
author name string	Han-Seong Kim Mi-Hwa Lee Young-Sik Kim Sang-Youb Han Young-Sun Kang Jee-Young Han Cy-Hyun Kim Dae-Ryong Cha Hye-Kyoung Song Hyoung-Kyu Kim Kum-Hyun Han Yi-Hwa Jee
OpenCitations bibliographic resource ID	4087431
rdfs:label	Spironolactone prevents diabetic nephropathy through an anti-inflammatory mechanism in type 2 diabetic rats (en) Spironolactone prevents diabetic nephropathy through an anti-inflammatory mechanism in type 2 diabetic rats (nl) Spironolactone prevents diabetic nephropathy through an anti-inflammatory mechanism in type 2 diabetic rats (ast)
skos:prefLabel	Spironolactone prevents diabetic nephropathy through an anti-inflammatory mechanism in type 2 diabetic rats (en) Spironolactone prevents diabetic nephropathy through an anti-inflammatory mechanism in type 2 diabetic rats (nl) Spironolactone prevents diabetic nephropathy through an anti-inflammatory mechanism in type 2 diabetic rats (ast)
name	Spironolactone prevents diabetic nephropathy through an anti-inflammatory mechanism in type 2 diabetic rats (en) Spironolactone prevents diabetic nephropathy through an anti-inflammatory mechanism in type 2 diabetic rats (nl) Spironolactone prevents diabetic nephropathy through an anti-inflammatory mechanism in type 2 diabetic rats (ast)
title	wds:Q28565932-F37E791E-16B3-465E-8ACE-56670E03D792
title	Spironolactone prevents diabetic nephropathy through an anti-inflammatory mechanism in type 2 diabetic rats (en)
page(s)	wds:Q28565932-92B9C38F-C5A3-4A0A-9FA1-7F1F80AE3308
page(s)	1362–1372
instance of	wds:Q28565932-4B1334AE-18B2-470F-9CDB-CC92759C965A
instance of	scholarly article
main subject	wds:Q28565932-72E49843-42F2-48AA-BC7A-D98DD31EEE1C wds:Q28565932-C28AB510-460F-4401-9A8D-DB5FED6FB24F
main subject	inflammation diabetic nephropathy
PubMed ID	wds:Q28565932-E0ABC5AE-B360-429B-838D-7756C9F9049B
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/16571782
PubMed ID	16571782
published in	wds:Q28565932-F649FA7B-3DFD-4F66-B598-DEE0FFEBB348
published in	Journal of the American Society of Nephrology
issue	wds:Q28565932-88A3B908-E5A6-4EEC-A1B7-AEF970CF78F0
volume	wds:Q28565932-09E5E417-7E78-45D4-9CFA-D8BD33F9DB49
issue	5
volume	17
DOI	wds:Q28565932-5FD821FF-1141-4E9B-83B0-C3AE6DF57FCA
DOI	http://dx.doi.org/10.1681/ASN.2005111196
DOI	10.1681/ASN.2005111196
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q28565932
is cites work of	Monocyte Chemoattractant Protein 1 (MCP-1) in obesity and diabetes Effect of mineralocorticoid receptor antagonist on insulin resistance and endothelial function in obese subjects Aldosterone and glomerular podocyte injury Inflammation in diabetic nephropathy Aldosterone activates NF-kappaB in the collecting duct. Effect of spironolactone combined with angiotensin-converting enzyme inhibitors and/or angiotensin II receptor blockers on chronic glomerular disease Blockade of CCL2/CCR2 signalling ameliorates diabetic nephropathy in db/db mice Local Mineralocorticoid Receptor Activation and the Role of Rac1 in Obesity-Related Diabetic Kidney Disease Pioglitazone attenuates diabetic nephropathy through an anti-inflammatory mechanism in type 2 diabetic rats Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathy. Aldosterone: a forgotten mediator of the relationship between psychological stress and heart disease Levels of NT-proBNP, markers of low-grade inflammation, and endothelial dysfunction during spironolactone treatment in patients with diabetic kidney disease. Role of T cells in type 2 diabetic nephropathy Increase in GLUT1 in smooth muscle alters vascular contractility and increases inflammation in response to vascular injury Diabetic nephropathy: the role of inflammation in fibroblast activation and kidney fibrosis Transforming growth factor beta 1 and monocyte chemoattractant protein-1 as prognostic markers of diabetic nephropathy Twenty years after ACEIs and ARBs: emerging treatment strategies for diabetic nephropathy Aldosterone-induced TGF-beta1 expression is regulated by mitogen-activated protein kinases and activator protein-1 in mesangial cells Spironolactone inhibits apoptosis in rat mesangial cells under hyperglycaemic conditions via the Wnt signalling pathway Spironolactone inhibits hyperglycemia-induced podocyte injury by attenuating ROS production. Increased renoprotection with ACE inhibitor plus aldosterone antagonist as compared to monotherapies--the effect on podocytes Inflammation and diabetic nephropathy Molecular mechanisms in the pathogenesis of diabetic nephropathy: an update Mineralocorticoid receptor blockade ameliorates peritoneal fibrosis in new rat peritonitis model The contribution of hypertension to diabetic nephropathy and retinopathy: the role of inflammation and oxidative stress Inflammation in diabetic kidney disease Renal ischemia-reperfusion injury is prevented by the mineralocorticoid receptor blocker spironolactone

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 190 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software